SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001553350-24-000040
Filing Date
2024-05-22
Accepted
2024-05-22 16:10:31
Documents
16
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A toi_10qa.htm   iXBRL 10-Q/A 38246
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7920
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 7936
  Complete submission text file 0001553350-24-000040.txt   294298

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE toi-20240331.xsd EX-101.SCH 3709
5 XBRL DEFINITION FILE toi-20240331_def.xml EX-101.DEF 26814
6 XBRL LABEL FILE toi-20240331_lab.xml EX-101.LAB 36913
7 XBRL PRESENTATION FILE toi-20240331_pre.xml EX-101.PRE 25438
19 EXTRACTED XBRL INSTANCE DOCUMENT toi_10qa_htm.xml XML 7698
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 843562323 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39248 | Film No.: 24973322
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)